Jianzhong Shentu

Phase I study of icotinib hydrochloride (BPI-2009H), an oral EGFR tyrosine kinase inhibitor, in patients with advanced NSCLC and other solid tumors

Qiong Zhao, Jianzhong Shentu, Nong Xu et al. · Lung Cancer · 2010 · 98 citations

Medicine, Oncology, Pharmacology +12

Determination of amlodipine in human plasma using automated online solid-phase extraction HPLC–tandem mass spectrometry: Application to a bioequivalence study of Chinese volunteers

Jianzhong Shentu, FU Li-zhi, Huili Zhou et al. · Journal of Pharmaceutical and Biomedical Analysis · 2012 · 40 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Open-label phase I clinical trial of Ad5-EBOV in Africans in China

Lihua Wu, Zhe Zhang, Hainv Gao et al. · Human Vaccines & Immunotherapeutics · 2017 · 37 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Hemostatic Efficiency and Wound Healing Properties of Natural Zeolite Granules in a Lethal Rabbit Model of Complex Groin Injury

Yunlong Li, Hui Li, Liping Xiao et al. · Materials · 2012 · 36 citations · Full text

Veterinary Medicine, Veterinary Surgery, Hemostasis +5

Determination of risperidone in human plasma by HPLC-MS/MS and its application to a pharmacokinetic study in Chinese volunteers

Mingzhu Huang, Jianzhong Shentu, Junchun Chen et al. · Journal of Zhejiang University SCIENCE B · 2008 · 36 citations

Pharmacy, Pharmacokinetics, Pharmacology +13